Lantheus Alpha Therapy, LLC
SEC insider (Form 3/4/5 filer). CIK 0002010224. 10% Owner at Perspective Therapeutics, Inc. (CATX). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 4, 2026. Located in BEDFORD, MA.
Companies Lantheus Alpha Therapy, LLC has filed insider reports for
- Perspective Therapeutics, Inc. (CATX): 10% Owner
Lantheus Alpha Therapy, LLC
CIK: 0002010224
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)5 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CATX
Perspective Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 4, 2026CATX
Perspective Therapeutics, Inc.
SaleDirect167.1K shares at avg. $3.15$526K - Sep 3, 2026CATX
Perspective Therapeutics, Inc.
SaleDirect80.8K shares at avg. $3.11$251K - Sep 2, 2026CATX
Perspective Therapeutics, Inc.
SaleDirect42.1K shares at avg. $3.11$131K - Sep 1, 2026CATX
Perspective Therapeutics, Inc.
SaleDirect35.8K shares at avg. $3.12$112K - Aug 31, 2026CATX
Perspective Therapeutics, Inc.
SaleDirect78.1K shares at avg. $3.14$246K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | CATX Perspective Therapeutics, Inc. | Sale | 167,149 | $3.15 | $526,051 | Direct |
| Sep 3, 2026 | CATX Perspective Therapeutics, Inc. | Sale | 80,783 | $3.11 | $250,896 | Direct |
| Sep 2, 2026 | CATX Perspective Therapeutics, Inc. | Sale | 42,129 | $3.11 | $131,219 | Direct |
| Sep 1, 2026 | CATX Perspective Therapeutics, Inc. | Sale | 35,769 | $3.12 | $111,574 | Direct |
| Aug 31, 2026 | CATX Perspective Therapeutics, Inc. | Sale | 78,145 | $3.14 | $245,610 | Direct |
1-5 of 5 transactions